|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,400.00 KRW | -7.28% |
|
-.--% | -46.15% |
| 25-10-01 | Investors left reading tea leaves | |
| 25-08-25 | Abpro Bio Co., Ltd.(KOSDAQ:A195990) dropped from S&P Global BMI Index | CI |
| Capitalization | 74.02B 50.12M 43.24M 39.04M 37.42M 68.01M 4.62B 71.11M 461M 185M 2.21B 188M 184M 7.93B | P/E ratio 2023 |
-5.89x | P/E ratio 2024 | -7.86x |
|---|---|---|---|---|---|
| Enterprise value | 74.41B 50.39M 43.47M 39.25M 37.62M 68.37M 4.64B 71.49M 463M 186M 2.22B 189M 185M 7.97B | EV / Sales 2023 |
5.8x | EV / Sales 2024 | 4.06x |
| Free-Float |
92.81% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | -7.28% | ||
| 1 month | -22.65% | ||
| 3 months | -51.22% | ||
| 6 months | -33.01% | ||
| Current year | -46.15% |
| 1 month | 1,390 | 1,920 | |
| Current year | 1,390 | 2,750 | |
| 1 year | 1,390 | 4,470 | |
| 3 years | 1,390 | 9,400 | |
| 5 years | 1,390 | 17,100 | |
| 10 years | 1,390 | 40,500 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jae-Yong Lee
CEO | Chief Executive Officer | 64 | 2024-04-29 |
Jong-Shik Hwang
SAM | Sales & Marketing | 56 | 2014-10-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jae-Yong Lee
BRD | Director/Board Member | 64 | 2019-08-22 |
Hyeong-Seok Kwon
BRD | Director/Board Member | 58 | 2020-04-08 |
Jin-Man Kwon
BRD | Director/Board Member | 56 | 2024-04-29 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.28% | -.--% | -57.06% | -64.65% | 26.99M | ||
| +1.50% | -4.25% | +75.93% | +41.00% | 2.91B | ||
| +2.02% | -2.94% | +8.58% | +28.21% | 2.85B | ||
| +2.45% | -6.56% | +17.82% | +33.09% | 2.26B | ||
| +4.31% | -12.34% | -18.49% | +15.62% | 2.24B | ||
| +4.21% | -7.11% | +82.88% | +303.43% | 2.08B | ||
| +2.20% | -4.46% | -16.23% | -3.24% | 1.95B | ||
| +8.21% | +8.53% | +215.73% | +78.66% | 1.86B | ||
| +4.52% | -5.06% | +213.67% | +233.96% | 1.84B | ||
| +11.66% | -1.63% | +127.30% | -25.71% | 1.83B | ||
| Average | +3.38% | -1.16% | +65.01% | +64.04% | 1.98B | |
| Weighted average by Cap. | +4.18% | +0.94% | +71.06% | +73.66% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 25.38B 17.18M 14.82M 13.39M 12.83M 23.31M 1.58B 24.38M 158M 63.37M 757M 64.51M 63.12M 2.72B | 31.66B 21.44M 18.5M 16.7M 16.01M 29.09M 1.98B 30.42M 197M 79.08M 945M 80.49M 78.76M 3.39B |
| Net income | -25.74B -17.43M -15.04M -13.58M -13.01M -23.65M -1.61B -24.73M -160M -64.29M -768M -65.44M -64.03M -2.76B | -15.63B -10.58M -9.13M -8.24M -7.9M -14.36M -975M -15.01M -97.34M -39.03M -466M -39.73M -38.88M -1.67B |
| Net Debt | -8.07B -5.47M -4.72M -4.26M -4.08M -7.42M -504M -7.76M -50.29M -20.17M -241M -20.53M -20.08M -865M | 396M 268K 231K 209K 200K 363K 24.68M 380K 2.46M 988K 11.81M 1.01M 984K 42.37M |
Employees
44
- Stock Market
- Equities
- A195990 Stock
Select your edition
All financial news and data tailored to specific country editions
















